Breakthrough in Cancer Detection: Nanoparticle-Based Biosensor Enables Early Diagnosis

Strategic Insights -

A team of researchers at the University of New South Wales has made a significant breakthrough in the field of cancer detection, using a nanoparticle-based 'dispersible electrodes' biosensor to detect ultra-low concentrations of microRNA-155 (miRNA-155) from a single breast cancer spheroid. This innovative approach enables early diagnosis and monitoring of cancer progression during treatment, revolutionizing the way cancer is detected and treated. The research has been supported by the Australian Research Council and the National Health & Medical Research Council (NHMRC) of Australia.

Key Takeaways:

  • The nanoparticle-based biosensor is capable of detecting ultra-low concentrations of miRNA-155 from a single breast cancer spheroid, enabling early diagnosis and monitoring of cancer progression during treatment.
  • The sensor's ability to measure biomarker expression from unaltered and undiluted cancer liquid biopsy from a single cancer spheroid opens the door to understanding key biological processes such as response to treatment on the cellular and molecular levels.
  • The research concludes that the ability to track dynamic biomarker changes in a single cancer spheroid paves the way for adapting liquid biopsy insights to guide oncologists and more personalized treatment strategies.
  • The study highlights the importance of understanding cancer heterogeneity, which is crucial for both understanding cancer and developing prognostic tools to monitor cancer progression during treatment.
  • The research was supported by the Australian Research Council and the National Health & Medical Research Council (NHMRC) of Australia.
  • The study was conducted by a team of researchers including Richard D. Tilley, Chen Hu, Essam M. Dief, Bram G. Soliman, Sara Romanazzo, Shilpa Rana, Kristopher A. Kilian, and J. Justin Gooding from the University of New South Wales.

Statistics:

  • The sensor is able to detect ultra-low concentrations of miRNA-155 from a single breast cancer spheroid.
  • The sensor's detection time is significantly shorter compared to standard real-time polymerase chain reaction analysis.
  • The research concludes that the ability to track dynamic biomarker changes in a single cancer spheroid opens the door to understanding key biological processes such as response to treatment on the cellular and molecular levels.

Sources:

  • Direct Detection of Microrna In Liquid Biopsies From Single Cancer Spheroids. Chemical Science, 2025.
  • Health & Medicine Week. May 23, 2025; p 5393.